A discovery strategy relying on the identification of fragments through resolution of a constitutional dynamicsystem, coupled to subsequent static ligand design and optimization, yielded a range of β‐galactosidase inhibitors. Inhibition studies provided important structural information for the compounds, of which 1‐thiobenzyl‐β‐D‐galactopyranoside demonstrated the best inhibitory effects.